| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |